Verastem CEO sells 2,000 shares at $10 under Rule 10b5-1
Verastem (VSTM) disclosed insider transactions by its President and CEO, reported as a director and officer.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Verastem (VSTM) disclosed insider transactions by its President and CEO, reported as a director and officer. On 11/03/2025, the reporting person sold 1,299 shares at $9.35 to satisfy statutory tax withholding tied to RSU vesting, and separately sold 2,000 shares at $10.00 pursuant to a Rule 10b5-1 trading plan. Following these transactions, the reporting person beneficially owned 438,818 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,299 | $9.35 | $12K |
| Sale | Common Stock | 2,000 | $10.00 | $20K |
Footnotes (2)
- F1. The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.
- F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did VSTM disclose in this Form 4?
Were any sales made under a pre-arranged plan?
What roles does the reporting person hold at Verastem (VSTM)?
What was the transaction date for the reported sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.